收费全文 | 23220篇 |
免费 | 1599篇 |
国内免费 | 96篇 |
耳鼻咽喉 | 233篇 |
儿科学 | 651篇 |
妇产科学 | 434篇 |
基础医学 | 3184篇 |
口腔科学 | 333篇 |
临床医学 | 2681篇 |
内科学 | 4712篇 |
皮肤病学 | 259篇 |
神经病学 | 2116篇 |
特种医学 | 795篇 |
外国民族医学 | 1篇 |
外科学 | 3217篇 |
综合类 | 273篇 |
一般理论 | 35篇 |
预防医学 | 2570篇 |
眼科学 | 465篇 |
药学 | 1509篇 |
中国医学 | 35篇 |
肿瘤学 | 1412篇 |
2023年 | 135篇 |
2022年 | 166篇 |
2021年 | 538篇 |
2020年 | 336篇 |
2019年 | 482篇 |
2018年 | 584篇 |
2017年 | 422篇 |
2016年 | 435篇 |
2015年 | 517篇 |
2014年 | 729篇 |
2013年 | 1020篇 |
2012年 | 1570篇 |
2011年 | 1741篇 |
2010年 | 944篇 |
2009年 | 784篇 |
2008年 | 1366篇 |
2007年 | 1583篇 |
2006年 | 1408篇 |
2005年 | 1426篇 |
2004年 | 1413篇 |
2003年 | 1282篇 |
2002年 | 1175篇 |
2001年 | 371篇 |
2000年 | 317篇 |
1999年 | 394篇 |
1998年 | 235篇 |
1997年 | 167篇 |
1996年 | 163篇 |
1995年 | 160篇 |
1994年 | 121篇 |
1993年 | 116篇 |
1992年 | 196篇 |
1991年 | 173篇 |
1990年 | 190篇 |
1989年 | 175篇 |
1988年 | 149篇 |
1987年 | 131篇 |
1986年 | 132篇 |
1985年 | 130篇 |
1984年 | 111篇 |
1983年 | 91篇 |
1982年 | 90篇 |
1981年 | 93篇 |
1980年 | 60篇 |
1979年 | 96篇 |
1978年 | 89篇 |
1977年 | 76篇 |
1976年 | 78篇 |
1974年 | 67篇 |
1973年 | 64篇 |
Background
Treatment of advanced anal squamous cell cancer (SCC) is usually with the combination of cisplatin and 5-fluorouracil, which is associated with heterogeneous responses across patients and significant toxicity. We examined the safety and efficacy of a modified schedule, FOLFCIS (leucovorin, fluorouracil, and cisplatin), and performed an integrated clinical and genomic analysis of anal SCC.Patients and Methods
We reviewed all patients with advanced anal SCC receiving first-line FOLFCIS chemotherapy – essentially a FOLFOX (leucovorin, fluorouracil, and oxaliplatin) schedule with cisplatin substituted for oxaliplatin – in our institution between 2007 and 2017, and performed deep sequencing to identify genomic markers of response and key genomic drivers.Results
Fifty-three patients with advanced anal SCC (48 metastatic; 5 unresectable, locally advanced) received first-line FOLFCIS during this period; all were platinum-naive. The response rate was 48% (95% confidence interval [CI], 32.6%-63%). With a median follow-up of 41.6 months, progression-free survival and overall survival were 7.1 months (95% CI, 4.4-8.6 months) and 22.1 months (95% CI, 16.9-28.1 months), respectively. Among all patients with advanced anal SCC that underwent sequencing during the study period, the most frequent genomic alterations consisted of chromosome 3q amplification (51%) and mutations in PIK3CA (29%) and KMT2D (22%). No genomic alteration correlated with response to platinum-containing treatment. Although there were few cases, patients with human papillomavirus-negative anal SCC did not appear to benefit from FOLFCIS, and all harbored distinct genomic profiles with TP53, TERT promoter, and CDKN2A mutations.Conclusions
FOLFCIS appears effective and safe as first-line chemotherapy in patients with advanced anal SCC and represents an alternative treatment option for these patients. 相似文献Methods: A cross-sectional prospective cohort study with 7-day follow-up was conducted. Body composition, cardiorespiratory fitness and biomarkers of cardiometabolic health were measured in thirty-three participants with SCI (> 1 year post injury). Physical activity dimensions were objectively assessed over 7-days.
Results: Activity energy expenditure (r =.43), physical activity level (r =.39), and moderate-to-vigorous physical activity (MVPA) (r =.48) were significantly (P < 0.001) associated with absolute (L/min) peak oxygen uptake (?O2 peak). ?O2 peak was significantly higher in persons performing ≥150 MVPA minutes/week compared to <40 minutes/week (P?=?0.003). Individual physical activity dimensions were not significantly associated with biomarkers of cardiometabolic health. However, body composition characteristics (BMI, waist and hip circumference) showed significant (P < 0.04), moderate (r >.30) associations with parameters of metabolic regulation, lipid profiles and inflammatory biomarkers. Relative ?O2 peak (ml/kg/min) was moderately associated with only insulin sensitivity (r?=?0.37, P?=?0.03).
Conclusions: Physical activity dimensions are associated with cardiorespiratory fitness; however, stronger and more consistent associations suggest that poor cardiometabolic health is associated with higher body fat content. Given these findings, the regulation of energy balance should be an important consideration for researchers and clinicians looking to improve cardiometabolic health in persons with SCI. 相似文献